BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7645947)

  • 1. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
    Grubbs CJ; Steele VE; Casebolt T; Juliana MM; Eto I; Whitaker LM; Dragnev KH; Kelloff GJ; Lubet RL
    Anticancer Res; 1995; 15(3):709-16. PubMed ID: 7645947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
    Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
    Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
    Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
    Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prepubertal indole-3-carbinol treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Sprague-Dawley rats.
    Shimano N; Uehara N; Kiyozuka Y; Shikata N; Tsubura A
    In Vivo; 2007; 21(6):983-8. PubMed ID: 18210745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas.
    Zhang X; Malejka-Giganti D
    Anticancer Res; 2003; 23(3B):2473-9. PubMed ID: 12894530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.
    Christov K; Grubbs CJ; Shilkaitis A; Juliana MM; Lubet RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5488-96. PubMed ID: 17875779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of chemoprevention of indole-3-carbinol in N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.
    Kang JK
    IARC Sci Publ; 2002; 156():401-2. PubMed ID: 12484220
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemoprevention of rat mammary carcinogenesis by black tea polyphenols: modulation of xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation, apoptosis, and angiogenesis.
    Kumaraguruparan R; Seshagiri PB; Hara Y; Nagini S
    Mol Carcinog; 2007 Sep; 46(9):797-806. PubMed ID: 17415784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM; Alshafie GA; Seibert K; Koki AT; Masferrer JL; Harris RE
    Anticancer Res; 2001; 21(5):3425-32. PubMed ID: 11848504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles.
    Wattenberg LW; Loub WD
    Cancer Res; 1978 May; 38(5):1410-3. PubMed ID: 416908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid.
    Udeani GO; Gerhauser C; Thomas CF; Moon RC; Kosmeder JW; Kinghorn AD; Moriarty RM; Pezzuto JM
    Cancer Res; 1997 Aug; 57(16):3424-8. PubMed ID: 9270008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
    Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
    Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative efficacy of the opioid antagonist, naltrexone, on the initiation and promotion phases of rat mammary carcinogenesis.
    Koo KL; Tejwani GA; Abou-Issa H
    Anticancer Res; 1996; 16(4A):1893-8. PubMed ID: 8712718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
    Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of indomethacin and melatonin on 7, 12-dimethybenz/a/anthracene-induced mammary carcinogenesis in female Sprague-Dawley rats. A preliminary report.
    M ciková-Kalická K; Bojková B; Adámeková E; Mníchová-Chamilová M; Kubatka P; Ahlersová E; Ahlers I
    Folia Biol (Praha); 2001; 47(2):75-9. PubMed ID: 11321252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray.
    El-Bayoumy K; Narayanan BA; Desai DH; Narayanan NK; Pittman B; Amin SG; Schwartz J; Nixon DW
    Carcinogenesis; 2003 Sep; 24(9):1505-14. PubMed ID: 12844480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis.
    Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE
    Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S; Mevissen M; Löscher W
    Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.